Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDROXYSSc
2024-516050-22-00Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in systemic sclerosis (SSc) comparing Hydroxychloroquine add-on with Placebo add-on (2 arms). Started Aug 2024; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2024-516050-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516050-22-00.